White blood cell count decreased and Hepatic function abnormal

Summary:

Hepatic function abnormal is found among people with White blood cell count decreased, especially for people who are female, 50-59 old.

The study analyzes which people have Hepatic function abnormal with White blood cell count decreased. It is created by eHealthMe based on reports of 26 people who have White blood cell count decreased from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is White blood cell count decreased?

White blood cell count decreased is found to be associated with 2,080 drugs and 3,074 conditions by eHealthMe. Check the latest studies of White blood cell count decreased.

What is Hepatic function abnormal?

Hepatic function abnormal is found to be associated with 1,440 drugs and 2,021 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.



On Jul, 20, 2026

26 people who have White Blood Cell Count Decreased and Hepatic Function Abnormal are studied.

Would you have Hepatic function abnormal when you have White blood cell count decreased?

Gender of people who have White Blood Cell Count Decreased and experienced Hepatic Function Abnormal *:

  • female: 60 %
  • male: 40 %

Age of people who have White Blood Cell Count Decreased and experienced Hepatic Function Abnormal *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 12.5 %
  • 20-29: 0.0 %
  • 30-39: 8.33 %
  • 40-49: 0.0 %
  • 50-59: 50.0 %
  • 60+: 29.17 %

Common co-existing conditions for these people *:

  1. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 7 people, 26.92%
  2. Thrombocytopenia (decrease of platelets in blood): 3 people, 11.54%
  3. Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 3 people, 11.54%
  4. Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 11.54%
  5. Aspartate Aminotransferase Increased: 3 people, 11.54%
  6. Breast Cancer: 3 people, 11.54%
  7. Cervix Carcinoma (cancer of cervix): 2 people, 7.69%
  8. Oedema Peripheral (superficial swelling): 2 people, 7.69%
  9. Gamma-Glutamyltransferase Increased: 2 people, 7.69%
  10. Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 2 people, 7.69%

Common drugs taken by these people *:

  1. Furosemide: 4 people, 15.38%
  2. Methotrexate: 4 people, 15.38%
  3. Hydrocortisone Sodium Succinate: 3 people, 11.54%
  4. Sodium Bicarbonate: 3 people, 11.54%
  5. Cimetidine: 3 people, 11.54%
  6. Methylprednisolone Sodium Succinate: 2 people, 7.69%
  7. Fluconazole: 2 people, 7.69%
  8. Nifedipine: 2 people, 7.69%
  9. Mycophenolate Mofetil: 2 people, 7.69%
  10. Cyclophosphamide: 2 people, 7.69%

Common symptoms for these people *:

  1. Fever: 5 people, 19.23%
  2. Thrombocytopenia (decrease of platelets in blood): 4 people, 15.38%
  3. Constipation: 4 people, 15.38%
  4. High Blood Pressure: 3 people, 11.54%
  5. Alanine Aminotransferase Increased: 3 people, 11.54%
  6. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 3 people, 11.54%
  7. Stomatitis (inflammation of mucous membrane of mouth): 3 people, 11.54%
  8. Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 11.54%
  9. Diarrhea: 2 people, 7.69%
  10. Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hepatic function abnormal?

- Check whether Hepatic function abnormal is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hepatic function abnormal:

All the conditions that are associated with Hepatic function abnormal:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hepatic function abnormal and White blood cell count decreased, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: